1
项与 MVF-HER-2 (597-626) Vaccine(Indiana University) 相关的临床试验Phase Ib Active Immunotherapy Trial (Expansion) With a Combination of Two Chimeric (Trastuzumab-like and Pertuzumab-like) HER-2 B Cell Peptide Vaccine Emulsified in ISA 720 Adjuvant in Patients With Advanced Solid Tumors
This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.
100 项与 MVF-HER-2 (597-626) Vaccine(Indiana University) 相关的临床结果
100 项与 MVF-HER-2 (597-626) Vaccine(Indiana University) 相关的转化医学
100 项与 MVF-HER-2 (597-626) Vaccine(Indiana University) 相关的专利(医药)
100 项与 MVF-HER-2 (597-626) Vaccine(Indiana University) 相关的药物交易